Assessment of the anti-inflammatory effects of Swertia chirata in acute and chronic experimental models in male albino rats

Indian Journal of Pharmacology

Volumn 32, Issue 1, 2000, Pages 21-24

  Banerjee, Shivaji ^b   Sur, Tapas Kumar ^b   Mandal, Suvra ^a   Das, Prabhash Chandra ^a   Sikdar, Sridhar ^b  

^a Chemical Research Unit   (India)

^b BC Roy Postgraduate Institute of Basic Medical Sciences   (India)

Author keywords

1,5 Dihydroxy 3,8 dimethoxy xanthone; Diclofenac; Granuloma pouch; Inflammation; Oedema; Swertia chirata

Indexed keywords

1,5 DIHYDROXY 3,8 DIMETHOXY XANTHONE; DICLOFENAC; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANGIOSPERM; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHIRATA; CONTROLLED STUDY; GRANULOMA; MALE; NONHUMAN; PAW EDEMA; RAT;

EID: 0034049372     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nadkarni KM. Indian Materia Medica. Bombay, Popular Prakashan 1982;2:1184-5.
2. Islam CN, Dutta MK, Sikdar S. Some observation of Swertia chirata against acute inflammatory induced oedema in rat hind paw. Indian J Pharmacol 1985;17:24-7.
3. Mandal S, Das PC, Sidkar S, Islam CN, Dutta MK. Anti-inflammatory action of Swertia chirata. Fitoterapia 1992;63:80-3.
4. Ghosal S, Sharma PV, Chaudhuri PK, Bhattacharya SK. Chemical constituents of Gentianaceae XIV: teraoxygenated and pentaoxygenated xanthones of Swertia purpurascens Wall. J Pharm Sci 1975;64:55-60.
5. Ghosal S, Sharma PV, Jaiswal DK Chemical constituents of Gentianaceae XXIII: teraoxygenated and pentaoxygenated xanthone O-glucosides of Swertia angustifolia Buch-Ham. J Pharm Sci 1978;67:55-60.
6. Lin CN, Liou SS, Ko FN, Teng CM. Gamma-pyrone compounds IV: synthesis and anti-platelet effects of mono- and dioxygenated xanthones and xanthonoxypro-panolamine. J Pharm Sci 1993;82:11-6.
7. Teng CM, Lin CN, Ko FN, Cheng KL, Haung TF. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides. Biochem Pharmacol 1989;38:3791-5.
8. Lin CN, Liou SJ, Lee TH, Chaung YC, Won SJ. Xanthone derivatives as potential anti-cancer drugs. J Pharm Pharmacol 1996;48:539-44.
9. Rodriguez S, Wolfender JL, Hakizamungu E, Hostettmann K. An antifungal napthoquinone, xanthones and secoiridoids from Swertia calcina. Planta Med 1995;61:362-4.
10. Ignatushchenko MV, Winter RW, Bachinger HR Hinrichs DH, Hinrichs DJ, Riscoe MK. Xanthone as anti-malarial agents: studies of a possible mode of action. FEBS Lett 1997;409:67-73.
11. Habrone JB. Phytochemical methods. London, Champman and Hall 1973;pp. 1-20.
12. Ghosal S, Sharma PV, Chaudhuri RK, Bhattacharya SK. Chemical constituents of the gentianaceae V: tetraoxygenated xanthones of Swertia chirata Buch-Ham. J Pharm Sci 1973;62:926-30.
13. Winter CA, Risley EA, Nuss CW. Carrageenin-induced oedema in hind paw of the rats-an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.
14. Tonussi CR, Ferreira SH. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol 1994;251:173-9.
15. Selye H. On the mechanism through which hydrocortisone affects the resistance of tissue to injury. An experimental study with granuloma pouch technique. J Am Med Ass 1953;152:1207-13.
16. Robert A, Nezamis JE. The granuloma pouch as a routine assay for anti-phlogistic compounds. Acta Endocr 1957;25:105-7.
17. Chau TT. Analgesic testing in animal models. In: Pharmacological methods in the control of inflammation. Alan R Liss Inc., 1989;pp. 195-212.
18. Larsen GL, Henson PM. Mediators of inflammation. Ann Rev Immunol 1983;1:335-59.
19. Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs: differences and similarities. N Engl J Med 1991;324:1716-25.
20. Vane J, Booting R. Inflammation and the mechanism of action of antiinflammatory drugs. FASEB J 1987;1:89-96.
21. Byars NE, Ferraresi RW. Inhibition of rat intestinal anaphylaxis by various anti-inflammatory agents. Agents Actions 1980;10:252-7.
22. Warren KS. In: inflammation. Lepaw IH, Waed PA. New York. Academic Press, 1972, pp. 203.
23. Clark WG, Brates DC, Johnson AR. Kininins and other peptides. In: Goth's Pharmacology ed. 13th. Mosby Year Book 1991; pp. 209-19.
24. Margolius HS. Tissue kallikrienes and kinins regulation and roles in hypertensive and diabetic diseases. Annu Rev Pharmacol Toxicol 1989;29:343-8.
25. Greenwaid RA. Animal models for evaluation of arthritic drugs. Meth Find Clin Pharmacol 1991;13:75-83.
26. Wheeler-Aceto H, Cowan A. Neurogenic and tissue mediated components of formalin-induced oedema. Agents Actions 1991;34:264-9.